Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperphosphatemia in renal failure.

Eberhard Ritz1, Marie-Luise Gross

  • 1Department Internal Medicine and Pathology, Ruperto Carola University, Heidelberg, Germany. Prof.E.Ritz@t-online.de

Blood Purification
|January 4, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vascular injury biomarkers and stroke risk: A population-based study.

Neurology·2020
Same author

Biomarkers of Vascular Injury and Type 2 Diabetes: A Prospective Study, Systematic Review and Meta-Analysis.

Journal of clinical medicine·2019
Same author

Author Correction: Biomarkers of vascular injury in relation to myocardial infarction risk: A population-based study.

Scientific reports·2019
Same author

Biomarkers of vascular injury in relation to myocardial infarction risk: A population-based study.

Scientific reports·2019
Same author

Longitudinal airway remodeling in active and past smokers in a lung cancer screening population.

European radiology·2018
Same author

Different Relevance of Peripheral, Central or Nighttime Blood Pressure Measurements in the Prediction of Chronic Kidney Disease Progression in Patients with Mild or No-Proteinuria.

Kidney & blood pressure research·2018
Same journal

Peritoneal Glucose Uptake Reduction by Sodium-Glucose Co-Transporter 2 Inhibitors in Clinical Peritoneal Dialysis.

Blood purification·2026
Same journal

With the Generalization of AI and Algorithms, Will We Still Need a Nephrologist in the Dialysis Room?

Blood purification·2026
Same journal

Could serum CA125 aid the clinical assessment of volume status of end-stage kidney disease patients treated by peritoneal dialysis patients?

Blood purification·2026
Same journal

From Bench to Bedside: Implications and Interventions for Endotoxin Exposure in Lipopolysaccharide-Induced Apoptosis and Eryptosis.

Blood purification·2026
Same journal

Feasibility Study of a Smartphone App and Web Portal for Remote Monitoring of Chronic Kidney Disease and Peritoneal Dialysis populations: A mixed-method study.

Blood purification·2026
Same journal

Treatment of Focal Segmental Glomerulosclerosis in Low- and Middle-Income Countries: Emerging Extracorporeal Therapies.

Blood purification·2026
See all related articles

Hyperphosphatemia, high serum phosphate levels, predicts poor survival in dialysis patients. New calcium-free phosphate binders are needed to manage this condition and reduce cardiac mortality linked to vascular calcification.

Area of Science:

  • Nephrology
  • Endocrinology
  • Cardiovascular Medicine

Background:

  • Hyperphosphatemia is a significant predictor of mortality in dialysis patients.
  • In early renal failure, the body compensates for phosphate levels through increased excretion mediated by parathyroid hormone and FGF-23.
  • This compensatory mechanism fails around a glomerular filtration rate of 30 ml/min, leading to hyperphosphatemia.

Purpose of the Study:

  • To explore the link between hyperphosphatemia, vascular calcification, and cardiac mortality.
  • To highlight the need for novel phosphate-binding agents.
  • To discuss current and developing treatments for managing serum phosphate levels.

Main Methods:

  • Review of current understanding of phosphate regulation in renal failure.

Related Experiment Videos

  • Analysis of the mechanisms underlying vascular calcification.
  • Evaluation of existing and emerging phosphate binders.

    • Main Results:

    • Serum phosphate levels above 6 mg/dl are associated with increased cardiac mortality, largely due to vascular calcification.
    • Vascular calcification is an active process involving osteoblastic markers, not just passive precipitation.
    • Existing phosphate binders include sevelamer and lanthanum carbonate; trivalent iron preparations are under development.

    Conclusions:

    • Effective management of hyperphosphatemia is crucial for improving survival in dialysis patients.
    • Novel, calcium-free phosphate binders are essential to address the risks associated with high phosphate and calcium-phosphate product.
    • Further research into phosphate regulation and novel therapeutic strategies is warranted.